| Size & multiples | |||
| Market Cap | $4.44B | Enterprise Value | — |
| P/E (TTM) | 67.87× | PEG (trailing) | — |
| P/S | 8.20× | P/FCF | 28.59× |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | 3.50% | Buyback Yield | — |
| Owner Earnings (TTM) | $98.7M | Owner Earnings Yield | 2.22% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.92 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 13.58% |
| After-tax Cost of Debt | — | Synthetic credit rating | AAA ⚠ |
| Cost of Debt · embedded (pre-tax) | — | Cost of Debt · marginal (synthetic) | 4.40% |
| WACC | — | ROIC | — |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating. ⚠ coverage rests on a very small interest figure; the letter may overstate quality.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $0.82 · revenue TTM $541.7M · FCF TTM $155.3M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E, EV/EBITDA
P/E 87th · EV/EBITDA 88th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 67.9x | 24.4x | 13.0x–39.3x | 87 ↑rich |
| EV/EBITDA | 51.5x | 15.1x | 9.8x–24.4x | 88 ↑rich |
| FCF Yield | 2.9% | -7.8% | -34.7%–1.4% | 80 ↑strong |
| Net Margin | 12.8% | -21.2% | -325.3%–7.2% | 82 ↑strong |
| Operating Margin | 11.2% | -34.5% | -552.0%–8.0% | 80 ↑strong |
| ROE | 5.3% | -36.8% | -92.5%–4.5% | 76 ↑strong |
